Showing 1-10 results of 20
Blood Disorders|Cancer
New study drug for Relapsed/Refractory CLL or SLL
This study will evaluate the safety, tolerability and effectiveness of an investigational oral drug called NX-5984 in patients with relapsed/refractory...
Cancer|Lung Disorders|Pulmonary Medicine
New investigational drug for treatment of advanced Non-Small Cell Lung Cancer
The purpose of this study is to evaluate the safety and effectiveness of the study drug, called PF-08634404, in combination with different anticancer agents...
Cancer
Investigational drug for CLL or SLL blood cancers
This study will compare an investigational drug to usual treatment for Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia
Cancer
New investigational drug for metastatic head and neck squamous cell carcinoma
This study will test the safety and effectiveness of investigational drug, Amivantamab, in combination with other approved anti-cancer medications for...
Cancer
New investigational drug for treatment of malignant solid tumors
The purpose of this study is to evaluate the safety and effectiveness of investigational drug BL-M07D1 for HER2 positive advanced malignant solid tumors.
Cancer
New study for men with high-risk prostate cancer with a known BRCA mutation.
This study will compare an investigational drug (saruparib [AZD5305]) versus placebo, added to a standard radiotherapy/androgen deprivation therapy (ADT)...
Cancer|Gynecology and Obstetrics
New investigational drug for treatment of platinum-resistant ovarian cancer
This study will evaluate the safety and effectiveness of investigational oral drug INCB123667 in patients with platinum-resistant ovarian, fallopian tube, or...
Cancer|Gastroenterology
Investigational drug for metastatic pancreatic ductal adenocarcinoma
This study will evaluate the safety and effectiveness of investigational oral drug BMS-986504 in combination with standard chemotherapy in patients with...
Cancer|Gynecology and Obstetrics
New study for Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer
This study will evaluate the safety and effectiveness of carboplatin + Mirvetuximab Soravtansine (MIRV). Subjects will receive up to 6 cycles of carboplatin...
Cancer|Gynecology and Obstetrics
New investigational drug for endometrial cancer
The purpose of this study is to evaluate the safety and effectiveness of investigational drug AZD8205 in comparison to standard of care treatment for...